Long-term outcome of male-limited gonadotropin-independent precocious puberty

Hormone Research in Paediatrics

Volumn 48, Issue 5, 1997, Pages 235-239

  Bertelloni, Silvano ^a   Baroncelli, Giampiero I ^a   Lala, Roberto ^b   Cappa, Marco ^c   Matarazzo, Patrizia ^b   Sanctis, Carlo De ^b   Saggese, Giuseppe ^a  

^a UNIVERSITY OF PISA   (Italy)

^b Regina Margherita Paediatric Hospital   (Italy)

^c BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

Cyproterone acetate; Final height; Growth; Ketoconazole; Male limited precocious puberty; Testicular failure

Indexed keywords

BUSERELIN; CYPROTERONE ACETATE; GONADOTROPIN; KETOCONAZOLE; TESTOSTERONE;

ADOLESCENT; ADULT; ARTICLE; BODY HEIGHT; CHILD; CHILD DEVELOPMENT; CLINICAL ARTICLE; DRUG EFFICACY; FAMILY HISTORY; HUMAN; MALE; OLIGOSPERMIA; PRECOCIOUS PUBERTY; PRIORITY JOURNAL; TESTIS DISEASE; TESTIS SIZE; TESTOSTERONE RELEASE; TREATMENT OUTCOME;

EID: 0030733509     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000185521     Document Type: Article

References (19)

1. Shankar R, Pescovitz OH: Precocious puberty. Adv EndocrMetab 1995;6:55-89.
2. Holland FG: Gonadotropin-independent precocious puberty. Endocrinol Metab Clin North Am 1991;20:191-210.
3. Holland FG, Fishman L, Bailey JD, Fazekas ATA: Ketoconazolc in the management of precocious puberty nor responsive to LH-RH analogue therapy. N Engl J Med 1985:312:1023-1028.
4. Lauc L, Jones J, Barnes KM, Cutler GB Jr: Treatment of familial male precocious puberty with spironolactone, tcstolactone. and deslore-lin. J Clin Endocrinol Metab 1993;76:151-155.
5. Tanner JM, Whitehouse RH, Takaisht M: Standards from birth to maturity for height, weight, height velocity and weight velocity: British children 1965. Arch Dis Child 1966:41: 454-471.
6. Tanner JM, Whitehouse RJ: Clinical longitudinal standards for height, weight, height velocity. weight velocity and stages of puberty. Arch Dis Child 1976:51:170-179.
7. Grculich WW, Pyle SI: Radiographic Atlas of Skeletal Development of the Hand and Wrist, ed 2. Stanford, Stanford University Press. 1959.
8. Bayley N, Pinncau SR: Tables for predicting adult height from skeletal age: Revised for use with Greulich-Pylc hand standard. J Pediatr 1952:40:423-441.
9. Zachmann M, Pradcr A, Kind H, Hailiger H, Budlingcr H: Testicular volume during adolescence. Cross-sectional and longitudinal studies. Helv Pacdiatr Acta 1974;29:61-72.
10. Kremer H, Kraaij R, van Reen M, Post M, Wit JM, Ottcn BC, Drop SLS, Dclemarrc-van de D, Waal HA, Pombo-Arias M, De Luca F, Potau N, Buckler JMH, Jansen M, Parks LS, Latif HA, Moll GW, Fpping W, Saggcse G, Mariman ECM, Themmen APN, Brunner HG: Mutation analysis of luteinizing hormone receptor gene in familial and sporadic patients with male-limited precocious puberty. J Clin Endocrinol Metab, in press.
11. Kraaij R, Post M, Kremer H, Milgrom E, Epping W, Brunner HG, Grootegocd JA, Themmen AP: A missense mutation in the second transmembrane segment of the luteinizing hormone receptor causes familial male-limited precocious puberty. J Clin Endocrinol Metab 1995;80:3168-3172.
12. Clark PA, Clarke WL: Testotoxicosis: An unusual presentation and novel gene mutation. Clin Pediatr 1995;34:271-274.
13. Evans BAJ, Bowen DJ, Smith PJ, Gregory JW: A new mutation of the l.H gene in a family with familial male precocious puberty (abstr. 55). Horm Res 1995:44(suppl 1): 15.
14. Stanhope R, Brook CGD, The clinical diagnosis of disorders of puberty: The loss of consonance. BrJ HospMed 1986;35:57-58.
15. Lint YJ, Low LCK: Familial testotoxicosis in a Chinese family. Eur J Pediatr 1994; 153:241-244.
16. Reiter EO, Brown RS, Longscope C, Beilins IZ: Male-limited familial precocious puberty in three generations: Apparent Levdig-cell autonomy and elevated glycoprotein hormone alpha subunit. N Engl J Med 1984:311:515-519.
17. Jacobsen AW, Macklin MT: Hereditary sexual precocity: Report of a family with 27 affected members. J Pediatr 1952;9:682-695.
18. Bcas F, Zurbrugg RP, Leibow SG, Patton RG, Gardner LI: Familial male sexual precocity: Report of the eleventh kindred found, with observations on blood group linkage and urinary C19-sleroids excretion. J Clin Endocrinol Metab 1962;22:1095-1102.
19. Babovic-Vuksanovic D, Donaldson MDC, Gibson NA, Wallace AM: Hazards of ketocon-azole therapy in testotoxicosis. Acta Pacdiatr 1994:83:994-997.